Will Body Odor Come Back After Surgery? The Truth About Apocrine Gland Residue

One of the most disheartening post-surgical experiences is discovering that underarm odor has returned weeks or months after an axillary odor procedure. When this happens, the explanation is almost always the same: apocrine glands (the specialized sweat glands that produce body odor when their secretions contact skin bacteria) were not completely removed.

Understanding this mechanism helps you evaluate surgical options and maintain realistic expectations after treatment.

Residual Apocrine Tissue: The Root of Recurrence

Apocrine glands are clustered in the superficial subcutaneous fat layer just beneath the dermis, distributed unevenly across the entire axillary area. The glands themselves are odorless; their secretions only develop the characteristic underarm odor after bacterial decomposition on the skin surface (for the full mechanism, see How Apocrine Glands Produce Body Odor).

As long as any residual gland tissue remains active, secretion continues. When odor disappears after surgery and then returns, this almost always reflects reactivation of residual glands rather than de-novo gland formation.

Key point: Post-surgical body odor "recurrence" is nearly always caused by incomplete gland removal, not by new gland growth. The sooner odor returns after surgery, the greater the likely residual burden.

Why Conventional Blind Curettage Leaves Glands Behind

Traditional curettage — sometimes called "blind scraping" — involves making an incision and removing subcutaneous tissue without real-time imaging guidance, relying entirely on tactile feedback. This approach has several structural limitations:

1. No visual confirmation — The surgeon cannot confirm in real time whether the correct tissue layer is being addressed at adequate depth.
2. Peripheral glands are easily missed — The actual gland distribution zone typically extends beyond what tactile assessment alone can determine, leaving peripheral areas at high residual risk.
3. Variable gland layer depth — Apocrine layer depth differs significantly between individuals; without imaging it is difficult to calibrate depth consistently across the operative field.
4. The trade-off between thoroughness and flap safety — Deeper curettage improves clearance but risks flap necrosis; more conservative technique protects the flap but leaves more residual tissue.

Key point: The limitations of blind curettage are structural, not a reflection of individual surgeon skill. Any approach that lacks intraoperative imaging faces the same constraints.

Ultrasound-Guided Rotary Excision: Seeing Before Clearing

Ultrasound-guided surgery with a rotary cutter changes the fundamental premise: operative decisions are guided by real-time visualization:

• Pre- and intraoperative ultrasound mapping: The apocrine layer depth, extent, and thickness are confirmed on imaging before and during the procedure.
• Rotary cutter under guidance: The rotary excision tip enters through an extreme minimal-incision approach (<20% of lesion width) and systematically addresses the confirmed target layer under visual guidance.
• Intraoperative re-check: After the initial pass, ultrasound confirms the cleared zone and identifies any remaining tissue at the margins.

This "map → clear → confirm" loop allows clearance quality to be assessed during the procedure rather than inferred only from long-term follow-up results.

See Axillary Odor Treatment Comparison and the Post-Surgery Wound Care Guide for additional technical detail.

Comparing Clearance Completeness by Technique

What Post-Surgical Follow-Up Is Actually Tracking

Any surgical result is subject to individual variation, and that has to be the starting point for judging outcomes.

Our approach is to treat complete apocrine tissue removal as the surgical goal, then use structured follow-up to check whether residual glands remain active. On long-term clinical follow-up, odor returning after a thorough clearance has been uncommon. That reflects procedural standards and follow-up quality; individual results still vary.

Factors beyond clearance completeness that influence post-surgical odor include: individual apocrine gland activity level (partly genetic), total gland distribution area and density, and pre- and post-operative hygiene practices.

Before surgery, it is worth asking your surgeon directly: Which technique will be used? How will clearance extent be confirmed intraoperatively? What is the post-surgical follow-up plan? These answers will tell you more than any general description of results.

Why Antiperspirants Are Not a Long-Term Solution

Some patients whose odor returns after surgery turn to antiperspirants or deodorants as an ongoing management strategy. These products can temporarily suppress odor (deodorants) or reduce local sweat volume (antiperspirants, via aluminum salt pore occlusion), but neither removes residual apocrine tissue. The underlying source continues secreting.

For a complete breakdown of how antiperspirant and deodorant mechanisms work — and why they can't solve a gland-level problem — see Why Antiperspirants and Deodorants Are Not Enough.

When to Schedule a Return Evaluation

Contact the clinic for an earlier review if any of these apply after surgery:

• Odor returns to pre-surgical levels within 2–3 months of the procedure
• Antiperspirants can no longer manage the odor
• One axilla has noticeably more odor than the other post-operatively

At a follow-up visit, ultrasound can assess whether residual gland tissue is still present and whether supplementary treatment is indicated. In some cases a second targeted clearance procedure addresses the issue directly; in others the finding may reflect high individual gland activity requiring a different management approach.

If you have questions about post-operative care or follow-up after a prior procedure, feel free to contact the clinic.

Common questions

Does recurrence mean the glands grew back?

No. When the smell returns, it is almost always residual glands becoming active again rather than new glands forming. The pattern is consistent: the faster the odor comes back, the more tissue was usually left behind.

How soon after surgery does a returning odor count as a problem?

If the smell is back at roughly pre-operative level within two to three months, if antiperspirant cannot hold it at all, or if one side is clearly stronger than the other, I would bring the follow-up forward rather than wait for the scheduled visit.

Why do some people have no odor afterwards while I still do?

Completeness of clearance is part of it, not all of it. How active your apocrine glands are to begin with (partly inherited), how wide the axillary area and how densely the glands sit in it, and care before and after surgery all feed into what is left. The same technique does not land the same way in every person.

If blind curettage left glands behind, was the surgeon not skilled enough?

Usually not. The limitation sits in the method: without imaging there is no way to confirm the plane and the area being cleared while operating, and the depth of the gland layer varies from person to person. A careful surgeon meets the same structural limit.

I have already had surgery and the odor is still there. Can anything more be done?

Start with a follow-up and an ultrasound to see whether gland tissue remains. If residual tissue is the issue, supplementary clearance is possible in some cases. If the glands are simply more active in your case, the conversation is about whether and when to add further treatment, not about repeating the same step.

This article was medically reviewed by Dr. Ta-Ju Liu and written in compliance with Taiwan Medical Care Act regulations. It does not constitute individualized medical advice. Please schedule a clinic consultation for a personalized treatment plan.